“An improved vaccine would ideally generate a resident memory population in the nasal mucosa or at the site of entry itself ... intranasal vaccination induced better cross-protection against different ...

Asian businesswoman uses a rapid self-test of antigens. An Asian businesswoman uses a rapid self-test of antigens using a cotton swab to prick her nose to detect the coronavirus, COVID-19. rapid ...

Findings indicate a sharp drop in immunity after Omicron infection, stressing the necessity for updated vaccines to enhance ...

Disinfecting surfaces is crucial in keeping bacteria and viruses at bay, but the cleaning solutions could be ineffective if ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

For the 2024 tax filing season, the South African Revenue Service (SARS) made a significant change for trusts, giving them their own filing window. Previously, filing for trusts aligned with ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

Following the infection with the viral antigen, adaptive immune responses are ... part of the defense mechanism and in the development of nasal vaccines. Here, we interpret the recent SARS-CoV-2 ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...